ZA915056B - Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages - Google Patents

Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages

Info

Publication number
ZA915056B
ZA915056B ZA915056A ZA915056A ZA915056B ZA 915056 B ZA915056 B ZA 915056B ZA 915056 A ZA915056 A ZA 915056A ZA 915056 A ZA915056 A ZA 915056A ZA 915056 B ZA915056 B ZA 915056B
Authority
ZA
South Africa
Prior art keywords
terminal
internucleotide linkages
oligonucleotide analogs
linkages
nuclease
Prior art date
Application number
ZA915056A
Other languages
English (en)
Inventor
Hannelore Roesch
Roesch Hannelore
Matthias Montenarh
Montenarh Matthias
Anja Froehlich
Froehlich Anja
Hartmut Seliger
Seliger Hartmut
Jose Flavio Ramalho-Ortigao
Flavio Ramalho-Ortigao Jose
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA915056B publication Critical patent/ZA915056B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Power Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polyesters Or Polycarbonates (AREA)
ZA915056A 1990-07-02 1991-07-01 Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages ZA915056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02

Publications (1)

Publication Number Publication Date
ZA915056B true ZA915056B (en) 1992-03-25

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915056A ZA915056B (en) 1990-07-02 1991-07-01 Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages

Country Status (22)

Country Link
US (1) US5750669A (de)
EP (1) EP0464638B1 (de)
JP (1) JP3186795B2 (de)
KR (1) KR100200400B1 (de)
AT (1) ATE151076T1 (de)
AU (1) AU647143B2 (de)
CA (1) CA2045891C (de)
CZ (1) CZ285408B6 (de)
DE (1) DE59108644D1 (de)
DK (1) DK0464638T3 (de)
ES (1) ES2099718T3 (de)
FI (1) FI104177B (de)
GR (1) GR3023432T3 (de)
HU (1) HU215147B (de)
IE (1) IE912309A1 (de)
IL (1) IL98672A (de)
NO (1) NO303018B1 (de)
NZ (1) NZ238769A (de)
PT (1) PT98169B (de)
SK (1) SK279544B6 (de)
TW (1) TW206232B (de)
ZA (1) ZA915056B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
ES2103408T3 (es) * 1992-09-24 1997-09-16 Hoechst Ag Analogos de oligorribonucleotidos y ribozimas con uniones terminales en 3'-3' o 5'-5' respectivamente.
WO1994022891A1 (en) * 1993-03-31 1994-10-13 Sterling Winthrop Inc. Oligonucleotides with amide linkages replacing phosphodiester linkages
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) * 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′-单磷酸化寡核苷酸
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (de) 2000-04-13 2007-01-10 Medical University of South Carolina Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
AU2001272714A1 (en) * 2000-06-13 2001-12-24 Proligo Llc Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
JP2004509970A (ja) * 2000-09-26 2004-04-02 ハイブリドン・インコーポレイテッド 位置的化学変化による免疫刺激オリゴヌクレオチドアナログの免疫刺激活性の調節
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
EP1460898A4 (de) * 2002-01-03 2006-05-24 Univ Texas Wt1-antisense-oligos für die hemmung von brustkrebs
WO2003066649A1 (en) * 2002-02-04 2003-08-14 Biomira Inc. Immunostimulatory, covalently lipidated oligonucleotides
EP1560839A4 (de) 2002-11-05 2008-04-23 Isis Pharmaceuticals Inc Chimäre oligomere verbindungen und derenverwendung in der genmodulation
AU2003291755A1 (en) 2002-11-05 2004-06-07 Isis Pharmaceuticals, Inc. Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
WO2005121372A2 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
EP2781523A1 (de) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophile Oligonukleotid-Analoga
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
ES2844180T3 (es) * 2016-04-08 2021-07-21 Translate Bio Inc Acido nucleico codificante multimérico y usos del mismo
JP2020522510A (ja) 2017-06-02 2020-07-30 ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. オリゴヌクレオチド組成物及びその使用方法
MX2020010687A (es) * 2018-04-12 2021-01-20 Wave Life Sciences Ltd Composiciones de oligonucleotidos y metodos de uso de las mismas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0406309A4 (en) * 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
WO1990012022A1 (en) * 1989-03-31 1990-10-18 University Patents, Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
EP0464638B1 (de) 1997-04-02
FI104177B1 (fi) 1999-11-30
TW206232B (de) 1993-05-21
EP0464638A2 (de) 1992-01-08
HUT62010A (en) 1993-03-29
FI104177B (fi) 1999-11-30
CA2045891A1 (en) 1992-01-03
IL98672A0 (en) 1992-07-15
IE912309A1 (en) 1992-01-15
DE59108644D1 (de) 1997-05-07
ES2099718T3 (es) 1997-06-01
AU647143B2 (en) 1994-03-17
CA2045891C (en) 2003-07-22
IL98672A (en) 1995-12-08
NO303018B1 (no) 1998-05-18
NO912585L (no) 1992-01-03
HU912215D0 (en) 1991-12-30
NZ238769A (en) 1993-11-25
AU7947591A (en) 1992-01-02
FI913169A (fi) 1992-01-03
HU215147B (hu) 2000-03-28
SK279544B6 (sk) 1998-12-02
KR100200400B1 (ko) 1999-06-15
CS201491A3 (en) 1992-01-15
FI913169A0 (fi) 1991-06-28
JPH05222088A (ja) 1993-08-31
EP0464638A3 (en) 1992-09-02
CZ285408B6 (cs) 1999-08-11
GR3023432T3 (en) 1997-08-29
JP3186795B2 (ja) 2001-07-11
ATE151076T1 (de) 1997-04-15
NO912585D0 (no) 1991-07-01
KR920002625A (ko) 1992-02-28
DK0464638T3 (da) 1997-10-13
PT98169B (pt) 1998-12-31
US5750669A (en) 1998-05-12
PT98169A (pt) 1993-09-30

Similar Documents

Publication Publication Date Title
ZA915056B (en) Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages
WO1991006626A3 (en) Triple helix formation in oligonucleotide therapy
NO171981C (no) Alkynylaminonukleotider, fremgangsmaate for fremstilling derav, 7-jodnukleotider, merkede alkynyl-aminonukleotider samt fremgangsmaate for fremstilling av 7-(3-amino-1-propynyl)-2',3'-dideoxyguanosin-5'-trifosfat
EP0651759A4 (de) 2'-0-alkyl-nukleoside und-phosphoramidite, verfahren zu ihrer herstellung und ihre verwendungen.
MA22905A1 (fr) Nouvelles sequences d'adn .
FR2569421B1 (fr) Plasmide et fragment d'adn comprenant un gene pour la resistance a la tetracycline, culture de microorganisme contenant le plasmide precite et microorganisme contenant ledit fragment d'adn
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
GR3004988T3 (de)
LTIP1519A (en) Solution, set, process for elongation of the oligonucleotidic primer, process of dna amplification
FR2645157B1 (fr) Inhibition selective de l'adn polymerase
GB2197651B (en) Rna polymerase gene microorganism having said gene and the production of rna polymerase by the use of said microorganism
AU629423B2 (en) Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
WO1993013204A3 (de) Mittel zur stimulierung der teilungsaktivität tierischer zellen
Johnstone Geology of the Stoughton-Roquemaure group, Beatty and Munro townships, northeastern Ontario.
Gharavi Molecular cloning of the human lipoxygenase gene
Lam The ribosomal RNA genes of Halobacterium cutirubrum
DE69011293D1 (de) Verfahren zur Herstellung von 4,4'-Dihydroxybiphenyl.
CA2143442A1 (en) Dorsal tissue affecting factor and compositions
DE3788618D1 (de) Verfahren zur Herstellung von Thiazolo-(2,3-b)-chinazolonen.
AU6029090A (en) Improvements in or relating to organic compounds
IT214763Z2 (it) Struttura per l'aerazione di scantinati.